E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Under Mission Poshan 2.0, supplementary nutrition is provided to children aged six months to six years, pregnant women, lactating mothers and eligible adolescent girls.
imphoenix82
Apollo TeleHealth has crossed one million teleconsultations through its Keonjhar Digital Dispensary Initiative.
imphoenix82
Toxics Link welcomed the Maharashtra FDA’s crackdown on skin-lightening products containing unsafe levels of mercury, describing it as a critical public health intervention that should be replicated nationwide.
imphoenix82
Traferox’s TorEx Lung Perfusion System allows donor lungs to be evaluated outside the body before transplantation, helping clinicians safely utilize organs that might otherwise be rejected.
imphoenix82
With the acquisition of the manufacturing business of Oriflame India, Akums aims to expand its existing footprint in skincare cosmetics and wellness products manufacturing while marking its foray into colour cosmetics manufacturing.
imphoenix82
Eligible BPL families in Karnataka can now access government-approved cashless IVF treatment at select Milann centres under the SAST and Ayushman Bharat Arogya Karnataka schemes.
imphoenix82
More than 500,000 arthroscopic meniscectomies are performed annually in the US, costing an estimated US$4 billion each year, a study has revealed, highlighting the continued use of unnecessary knee surgery in adults with degenerative meniscus tears.
imphoenix82
CDSCO has issued the Guidance Document on Medical Device Software to align India’s regulatory requirements with globally harmonized practices and streamline approvals.
imphoenix82
Zydus’ Desidustat received approval from the Drug Controller General of India (DCGI) in March 2022 for the treatment of anaemia in patients with chronic kidney disease (CKD).
imphoenix82
BRIJ Medical has expanded its incision management portfolio, with the launch of BRIJ-SEAL, a hypoallergenic wound sealant offering a 14-day bacterial barrier to seal and protect post-operative incisions.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
